| Symbol |
Name |
|
A1CF
|
APOBEC1 complementation factor
|
|
A3GALT2
|
alpha 1,3-galactosyltransferase 2
|
|
AAAS
|
achalasia, adrenocortical insufficiency, alacrimia
|
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCC10
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 10
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACKR1
|
atypical chemokine receptor 1 (Duffy blood group)
|
|
ACTB
|
actin, beta
|
|
ADA
|
adenosine deaminase
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADAM33
|
ADAM metallopeptidase domain 33
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADAMTS4
|
ADAM metallopeptidase with thrombospondin type 1 motif, 4
|
|
ADAR
|
adenosine deaminase, RNA-specific
|
|
ADGRE5
|
adhesion G protein-coupled receptor E5
|
|
ADGRG1
|
adhesion G protein-coupled receptor G1
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AGA
|
aspartylglucosaminidase
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALDH1A3
|
aldehyde dehydrogenase 1 family, member A3
|
|
ALOX12
|
arachidonate 12-lipoxygenase
|
|
ALOX15
|
arachidonate 15-lipoxygenase
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
ALOXE3
|
arachidonate lipoxygenase 3
|
|
AMH
|
anti-Mullerian hormone
|
|
AMHR2
|
anti-Mullerian hormone receptor, type II
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
APOA1
|
apolipoprotein A-I
|
|
APOB
|
apolipoprotein B
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOBEC3H
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H
|
|
APOE
|
apolipoprotein E
|
|
APOL1
|
apolipoprotein L, 1
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP4
|
aquaporin 4
|
|
AR
|
androgen receptor
|
|
ARF1
|
ADP-ribosylation factor 1
|
|
AS3MT
|
arsenite methyltransferase
|
|
B2M
|
beta-2-microglobulin
|
|
B3GAT1
|
beta-1,3-glucuronyltransferase 1
|
|
BACE1
|
beta-site APP-cleaving enzyme 1
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BDKRB2
|
bradykinin receptor B2
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BECN1
|
beclin 1, autophagy related
|
|
BIRC7
|
baculoviral IAP repeat containing 7
|
|
BOK
|
BCL2-related ovarian killer
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BST2
|
bone marrow stromal cell antigen 2
|
|
C3
|
complement component 3
|
|
CALR
|
calreticulin
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CAP1
|
CAP, adenylate cyclase-associated protein 1 (yeast)
|
|
CAPN3
|
calpain 3, (p94)
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CCK
|
cholecystokinin
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL23
|
chemokine (C-C motif) ligand 23
|
|
CCL25
|
chemokine (C-C motif) ligand 25
|
|
CCL26
|
chemokine (C-C motif) ligand 26
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
|
CCL4
|
chemokine (C-C motif) ligand 4
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCND1
|
cyclin D1
|
|
CCR1
|
chemokine (C-C motif) receptor 1
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR4
|
chemokine (C-C motif) receptor 4
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR6
|
chemokine (C-C motif) receptor 6
|
|
CCR9
|
chemokine (C-C motif) receptor 9
|
|
CCRL2
|
chemokine (C-C motif) receptor-like 2
|
|
CD160
|
CD160 molecule
|
|
CD1A
|
CD1a molecule
|
|
CD1B
|
CD1b molecule
|
|
CD1C
|
CD1c molecule
|
|
CD1D
|
CD1d molecule
|
|
CD2
|
CD2 molecule
|
|
CD226
|
CD226 molecule
|
|
CD244
|
CD244 molecule, natural killer cell receptor 2B4
|
|
CD247
|
CD247 molecule
|
|
CD27
|
CD27 molecule
|
|
CD274
|
CD274 molecule
|
|
CD276
|
CD276 molecule
|
|
CD300A
|
CD300a molecule
|
|
CD300C
|
CD300c molecule
|
|
CD4
|
CD4 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD47
|
CD47 molecule
|
|
CD48
|
CD48 molecule
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD58
|
CD58 molecule
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
|
CD69
|
CD69 molecule
|
|
CD7
|
CD7 molecule
|
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
|
CD80
|
CD80 molecule
|
|
CD86
|
CD86 molecule
|
|
CD96
|
CD96 molecule
|
|
CD99
|
CD99 molecule
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFH
|
complement factor H
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGA
|
glycoprotein hormones, alpha polypeptide
|
|
CHRM3
|
cholinergic receptor, muscarinic 3
|
|
CHRNB2
|
cholinergic receptor, nicotinic, beta 2 (neuronal)
|
|
CISD1
|
CDGSH iron sulfur domain 1
|
|
CLCA2
|
chloride channel accessory 2
|
|
CLEC2D
|
C-type lectin domain family 2, member D
|
|
CMAHP
|
cytidine monophospho-N-acetylneuraminic acid hydroxylase, pseudogene
|
|
CMPK1
|
cytidine monophosphate (UMP-CMP) kinase 1, cytosolic
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
CNTFR
|
ciliary neurotrophic factor receptor
|
|
COL4A3BP
|
collagen, type IV, alpha 3 (Goodpasture antigen) binding protein
|
|
COL4A4
|
collagen, type IV, alpha 4
|
|
COL4A5
|
collagen, type IV, alpha 5
|
|
COL6A1
|
collagen, type VI, alpha 1
|
|
COPS8
|
COP9 signalosome subunit 8
|
|
CORT
|
cortistatin
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CRH
|
corticotropin releasing hormone
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CRHR2
|
corticotropin releasing hormone receptor 2
|
|
CRISPLD2
|
cysteine-rich secretory protein LCCL domain containing 2
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRYAB
|
crystallin, alpha B
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSN3
|
casein kappa
|
|
CTC1
|
CTS telomere maintenance complex component 1
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSC
|
cathepsin C
|
|
CTSK
|
cathepsin K
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CXCR5
|
chemokine (C-X-C motif) receptor 5
|
|
CXCR6
|
chemokine (C-X-C motif) receptor 6
|
|
CYB5R4
|
cytochrome b5 reductase 4
|
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP27A1
|
cytochrome P450, family 27, subfamily A, polypeptide 1
|
|
CYR61
|
cysteine-rich, angiogenic inducer, 61
|
|
DDR2
|
discoidin domain receptor tyrosine kinase 2
|
|
DEFB103B
|
defensin, beta 103B
|
|
DEFB4A
|
defensin, beta 4A
|
|
DEK
|
DEK proto-oncogene
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DMD
|
dystrophin
|
|
DOCK8
|
dedicator of cytokinesis 8
|
|
DOK1
|
docking protein 1, 62kDa (downstream of tyrosine kinase 1)
|
|
DOK2
|
docking protein 2, 56kDa
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DRD3
|
dopamine receptor D3
|
|
EDN1
|
endothelin 1
|
|
EDN2
|
endothelin 2
|
|
EDN3
|
endothelin 3
|
|
EGF
|
epidermal growth factor
|
|
EGFL7
|
EGF-like-domain, multiple 7
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN1
|
egl-9 family hypoxia-inducible factor 1
|
|
EGR1
|
early growth response 1
|
|
ELANE
|
elastase, neutrophil expressed
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
EPHA2
|
EPH receptor A2
|
|
EPHX2
|
epoxide hydrolase 2, cytoplasmic
|
|
ERAP1
|
endoplasmic reticulum aminopeptidase 1
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ESRRB
|
estrogen-related receptor beta
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F2RL2
|
coagulation factor II (thrombin) receptor-like 2
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
FAAH
|
fatty acid amide hydrolase
|
|
FADS1
|
fatty acid desaturase 1
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FCER1G
|
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FCRL6
|
Fc receptor-like 6
|
|
FGB
|
fibrinogen beta chain
|
|
FHL2
|
four and a half LIM domains 2
|
|
FLG
|
filaggrin
|
|
FLG2
|
filaggrin family member 2
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3LG
|
fms-related tyrosine kinase 3 ligand
|
|
FMR1
|
fragile X mental retardation 1
|
|
FOSL2
|
FOS-like antigen 2
|
|
FOXP3
|
forkhead box P3
|
|
FPR1
|
formyl peptide receptor 1
|
|
FPR2
|
formyl peptide receptor 2
|
|
FRZB
|
frizzled-related protein
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)
|
|
GALR2
|
galanin receptor 2
|
|
GALR3
|
galanin receptor 3
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA2
|
GATA binding protein 2
|
|
GBA
|
glucosidase, beta, acid
|
|
GCG
|
glucagon
|
|
GCNT1
|
glucosaminyl (N-acetyl) transferase 1, core 2
|
|
GLP1R
|
glucagon-like peptide 1 receptor
|
|
GLRA1
|
glycine receptor, alpha 1
|
|
GMDS
|
GDP-mannose 4,6-dehydratase
|
|
GMNN
|
geminin, DNA replication inhibitor
|
|
GNB3
|
guanine nucleotide binding protein (G protein), beta polypeptide 3
|
|
GNLY
|
granulysin
|
|
GOT1
|
glutamic-oxaloacetic transaminase 1, soluble
|
|
GPR18
|
G protein-coupled receptor 18
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
|
GREM1
|
gremlin 1, DAN family BMP antagonist
|
|
GRP
|
gastrin-releasing peptide
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSR
|
glutathione reductase
|
|
GSTA1
|
glutathione S-transferase alpha 1
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTM2
|
glutathione S-transferase mu 2 (muscle)
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GSTT2
|
glutathione S-transferase theta 2 (gene/pseudogene)
|
|
GSTZ1
|
glutathione S-transferase zeta 1
|
|
GYPA
|
glycophorin A (MNS blood group)
|
|
GZMA
|
granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3)
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
GZMH
|
granzyme H (cathepsin G-like 2, protein h-CCPX)
|
|
GZMK
|
granzyme K (granzyme 3; tryptase II)
|
|
GZMM
|
granzyme M (lymphocyte met-ase 1)
|
|
H2AFX
|
H2A histone family, member X
|
|
HACE1
|
HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1
|
|
HAS2
|
hyaluronan synthase 2
|
|
HAVCR1
|
hepatitis A virus cellular receptor 1
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HBA1
|
hemoglobin, alpha 1
|
|
HCST
|
hematopoietic cell signal transducer
|
|
HDC
|
histidine decarboxylase
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIF1AN
|
hypoxia inducible factor 1, alpha subunit inhibitor
|
|
HIST2H2BE
|
histone cluster 2, H2be
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HP
|
haptoglobin
|
|
HPR
|
haptoglobin-related protein
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSP90AB1
|
heat shock protein 90kDa alpha (cytosolic), class B member 1
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
HTR2C
|
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
|
|
IAPP
|
islet amyloid polypeptide
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFITM1
|
interferon induced transmembrane protein 1
|
|
IFN1@
|
interferon, type 1, cluster
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IFNL3
|
interferon, lambda 3
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IKZF2
|
IKAROS family zinc finger 2 (Helios)
|
|
IL10
|
interleukin 10
|
|
IL12A
|
interleukin 12A
|
|
IL12B
|
interleukin 12B
|
|
IL12RB1
|
interleukin 12 receptor, beta 1
|
|
IL13
|
interleukin 13
|
|
IL15
|
interleukin 15
|
|
IL15RA
|
interleukin 15 receptor, alpha
|
|
IL17A
|
interleukin 17A
|
|
IL17D
|
interleukin 17D
|
|
IL17F
|
interleukin 17F
|
|
IL17RB
|
interleukin 17 receptor B
|
|
IL18
|
interleukin 18
|
|
IL18BP
|
interleukin 18 binding protein
|
|
IL18R1
|
interleukin 18 receptor 1
|
|
IL18RAP
|
interleukin 18 receptor accessory protein
|
|
IL19
|
interleukin 19
|
|
IL2
|
interleukin 2
|
|
IL20
|
interleukin 20
|
|
IL21
|
interleukin 21
|
|
IL22
|
interleukin 22
|
|
IL27
|
interleukin 27
|
|
IL27RA
|
interleukin 27 receptor, alpha
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL2RG
|
interleukin 2 receptor, gamma
|
|
IL32
|
interleukin 32
|
|
IL37
|
interleukin 37
|
|
IL4
|
interleukin 4
|
|
IL6
|
interleukin 6
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
IL7
|
interleukin 7
|
|
IL9
|
interleukin 9
|
|
IRAK4
|
interleukin-1 receptor-associated kinase 4
|
|
IRGM
|
immunity-related GTPase family, M
|
|
ITGA1
|
integrin, alpha 1
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGA6
|
integrin, alpha 6
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB5
|
integrin, beta 5
|
|
ITGB6
|
integrin, beta 6
|
|
ITPA
|
inosine triphosphatase (nucleoside triphosphate pyrophosphatase)
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JAK3
|
Janus kinase 3
|
|
JUN
|
jun proto-oncogene
|
|
KCNN4
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4
|
|
KDM1A
|
lysine (K)-specific demethylase 1A
|
|
KIR2DL1
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1
|
|
KIR2DL2
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2
|
|
KIR2DL3
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3
|
|
KIR2DL4
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4
|
|
KIR2DS1
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1
|
|
KIR2DS2
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2
|
|
KIR2DS3
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 3
|
|
KIR2DS4
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4
|
|
KIR2DS5
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5
|
|
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
|
|
KIR3DL2
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2
|
|
KIR3DS1
|
killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KITLG
|
KIT ligand
|
|
KLK12
|
kallikrein-related peptidase 12
|
|
KLK13
|
kallikrein-related peptidase 13
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLRAP1
|
killer cell lectin-like receptor subfamily A pseudogene 1
|
|
KLRC1
|
killer cell lectin-like receptor subfamily C, member 1
|
|
KLRC2
|
killer cell lectin-like receptor subfamily C, member 2
|
|
KLRD1
|
killer cell lectin-like receptor subfamily D, member 1
|
|
KLRG1
|
killer cell lectin-like receptor subfamily G, member 1
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KMT2E
|
lysine (K)-specific methyltransferase 2E
|
|
KPNA2
|
karyopherin alpha 2 (RAG cohort 1, importin alpha 1)
|
|
KPNB1
|
karyopherin (importin) beta 1
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
LAG3
|
lymphocyte-activation gene 3
|
|
LALBA
|
lactalbumin, alpha-
|
|
LAMA5
|
laminin, alpha 5
|
|
LAT
|
linker for activation of T cells
|
|
LAT2
|
linker for activation of T cells family, member 2
|
|
LCAT
|
lecithin-cholesterol acyltransferase
|
|
LCP2
|
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)
|
|
LCT
|
lactase
|
|
LDLR
|
low density lipoprotein receptor
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LGALS3BP
|
lectin, galactoside-binding, soluble, 3 binding protein
|
|
LGALS9
|
lectin, galactoside-binding, soluble, 9
|
|
LIF
|
leukemia inhibitory factor
|
|
LILRA3
|
leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3
|
|
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
|
|
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2
|
|
LILRB4
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4
|
|
LPL
|
lipoprotein lipase
|
|
LST1
|
leukocyte specific transcript 1
|
|
LTA
|
lymphotoxin alpha
|
|
LYST
|
lysosomal trafficking regulator
|
|
MAFB
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B
|
|
MAP2K3
|
mitogen-activated protein kinase kinase 3
|
|
MAP2K6
|
mitogen-activated protein kinase kinase 6
|
|
MAP3K2
|
mitogen-activated protein kinase kinase kinase 2
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPT
|
microtubule-associated protein tau
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MCM4
|
minichromosome maintenance complex component 4
|
|
MCPH1
|
microcephalin 1
|
|
MDK
|
midkine (neurite growth-promoting factor 2)
|
|
MGP
|
matrix Gla protein
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MICB
|
MHC class I polypeptide-related sequence B
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR126
|
microRNA 126
|
|
MIR145
|
microRNA 145
|
|
MIR146A
|
microRNA 146a
|
|
MIR17
|
microRNA 17
|
|
MIR181A2
|
microRNA 181a-2
|
|
MIR183
|
microRNA 183
|
|
MIR20A
|
microRNA 20a
|
|
MIR30E
|
microRNA 30e
|
|
MIR378A
|
microRNA 378a
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MKNK1
|
MAP kinase interacting serine/threonine kinase 1
|
|
MLH1
|
mutL homolog 1
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MPO
|
myeloperoxidase
|
|
MRC1
|
mannose receptor, C type 1
|
|
MSH6
|
mutS homolog 6
|
|
MSN
|
moesin
|
|
MSTN
|
myostatin
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYOCD
|
myocardin
|
|
NAB2
|
NGFI-A binding protein 2 (EGR1 binding protein 2)
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NCR1
|
natural cytotoxicity triggering receptor 1
|
|
NCR2
|
natural cytotoxicity triggering receptor 2
|
|
NCR3
|
natural cytotoxicity triggering receptor 3
|
|
NCR3LG1
|
natural killer cell cytotoxicity receptor 3 ligand 1
|
|
NCS1
|
neuronal calcium sensor 1
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NHEJ1
|
nonhomologous end-joining factor 1
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NOD1
|
nucleotide-binding oligomerization domain containing 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NT5C1A
|
5'-nucleotidase, cytosolic IA
|
|
OBFC1
|
oligonucleotide/oligosaccharide-binding fold containing 1
|
|
OCLN
|
occludin
|
|
OLR1
|
oxidized low density lipoprotein (lectin-like) receptor 1
|
|
OPRM1
|
opioid receptor, mu 1
|
|
OXTR
|
oxytocin receptor
|
|
P2RY11
|
purinergic receptor P2Y, G-protein coupled, 11
|
|
PAEP
|
progestagen-associated endometrial protein
|
|
PAH
|
phenylalanine hydroxylase
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PCBP1
|
poly(rC) binding protein 1
|
|
PCSK9
|
proprotein convertase subtilisin/kexin type 9
|
|
PDCD1
|
programmed cell death 1
|
|
PDCD2
|
programmed cell death 2
|
|
PDCD2L
|
programmed cell death 2-like
|
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
|
PDYN
|
prodynorphin
|
|
PF4
|
platelet factor 4
|
|
PGK1
|
phosphoglycerate kinase 1
|
|
PGR
|
progesterone receptor
|
|
PI3
|
peptidase inhibitor 3, skin-derived
|
|
PIBF1
|
progesterone immunomodulatory binding factor 1
|
|
PIGA
|
phosphatidylinositol glycan anchor biosynthesis, class A
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PIP5K1A
|
phosphatidylinositol-4-phosphate 5-kinase, type I, alpha
|
|
PIP5K1C
|
phosphatidylinositol-4-phosphate 5-kinase, type I, gamma
|
|
PKLR
|
pyruvate kinase, liver and RBC
|
|
PLA2G6
|
phospholipase A2, group VI (cytosolic, calcium-independent)
|
|
PLA2G7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLCB1
|
phospholipase C, beta 1 (phosphoinositide-specific)
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PLG
|
plasminogen
|
|
PMEL
|
premelanosome protein
|
|
PMS1
|
PMS1 postmeiotic segregation increased 1 (S. cerevisiae)
|
|
POLA1
|
polymerase (DNA directed), alpha 1, catalytic subunit
|
|
POLL
|
polymerase (DNA directed), lambda
|
|
POLR2A
|
polymerase (RNA) II (DNA directed) polypeptide A, 220kDa
|
|
POMC
|
proopiomelanocortin
|
|
PON1
|
paraoxonase 1
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
POU5F1P4
|
POU class 5 homeobox 1 pseudogene 4
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PRDM1
|
PR domain containing 1, with ZNF domain
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRLR
|
prolactin receptor
|
|
PROCR
|
protein C receptor, endothelial
|
|
PROS1
|
protein S (alpha)
|
|
PROZ
|
protein Z, vitamin K-dependent plasma glycoprotein
|
|
PRTN3
|
proteinase 3
|
|
PSCA
|
prostate stem cell antigen
|
|
PTBP1
|
polypyrimidine tract binding protein 1
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
PVALB
|
parvalbumin
|
|
PVR
|
poliovirus receptor
|
|
RAD51
|
RAD51 recombinase
|
|
RAE1
|
ribonucleic acid export 1
|
|
RARRES2
|
retinoic acid receptor responder (tazarotene induced) 2
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RNASEL
|
ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent)
|
|
RPA1
|
replication protein A1, 70kDa
|
|
RPS17
|
ribosomal protein S17
|
|
RPS6KA3
|
ribosomal protein S6 kinase, 90kDa, polypeptide 3
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX3
|
runt-related transcription factor 3
|
|
RXRA
|
retinoid X receptor, alpha
|
|
S100A9
|
S100 calcium binding protein A9
|
|
SAA1
|
serum amyloid A1
|
|
SALL2
|
spalt-like transcription factor 2
|
|
SAMHD1
|
SAM domain and HD domain 1
|
|
SCARB1
|
scavenger receptor class B, member 1
|
|
SDC1
|
syndecan 1
|
|
SEMA4D
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D
|
|
SERPINA2
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 2 (gene/pseudogene)
|
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SFTPA1
|
surfactant protein A1
|
|
SFTPC
|
surfactant protein C
|
|
SH2D1A
|
SH2 domain containing 1A
|
|
SH2D1B
|
SH2 domain containing 1B
|
|
SH3BP2
|
SH3-domain binding protein 2
|
|
SHBG
|
sex hormone-binding globulin
|
|
SIGLEC7
|
sialic acid binding Ig-like lectin 7
|
|
SIGLEC8
|
sialic acid binding Ig-like lectin 8
|
|
SIGLEC9
|
sialic acid binding Ig-like lectin 9
|
|
SIRPA
|
signal-regulatory protein alpha
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLAMF1
|
signaling lymphocytic activation molecule family member 1
|
|
SLAMF6
|
SLAM family member 6
|
|
SLAMF7
|
SLAM family member 7
|
|
SLC11A1
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1
|
|
SLC24A5
|
solute carrier family 24 (sodium/potassium/calcium exchanger), member 5
|
|
SLC2A4
|
solute carrier family 2 (facilitated glucose transporter), member 4
|
|
SLC45A3
|
solute carrier family 45, member 3
|
|
SLC4A1
|
solute carrier family 4 (anion exchanger), member 1 (Diego blood group)
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SMAD3
|
SMAD family member 3
|
|
SMARCAL1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a-like 1
|
|
SMN1
|
survival of motor neuron 1, telomeric
|
|
SMUG1
|
single-strand-selective monofunctional uracil-DNA glycosylase 1
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SP1
|
Sp1 transcription factor
|
|
SPINK6
|
serine peptidase inhibitor, Kazal type 6
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPX
|
spexin hormone
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
SRY
|
sex determining region Y
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STMN1
|
stathmin 1
|
|
STX11
|
syntaxin 11
|
|
STXBP2
|
syntaxin binding protein 2
|
|
TAPBP
|
TAP binding protein (tapasin)
|
|
TARDBP
|
TAR DNA binding protein
|
|
TAS1R3
|
taste receptor, type 1, member 3
|
|
TAS2R14
|
taste receptor, type 2, member 14
|
|
TAS2R38
|
taste receptor, type 2, member 38
|
|
TAS2R50
|
taste receptor, type 2, member 50
|
|
TBX21
|
T-box 21
|
|
TBX5
|
T-box 5
|
|
TCF7
|
transcription factor 7 (T-cell specific, HMG-box)
|
|
TCP1
|
t-complex 1
|
|
TERC
|
telomerase RNA component
|
|
TERF2
|
telomeric repeat binding factor 2
|
|
TERT
|
telomerase reverse transcriptase
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
THBS1
|
thrombospondin 1
|
|
THRA
|
thyroid hormone receptor, alpha
|
|
THRB
|
thyroid hormone receptor, beta
|
|
TIE1
|
tyrosine kinase with immunoglobulin-like and EGF-like domains 1
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TIMP3
|
TIMP metallopeptidase inhibitor 3
|
|
TINF2
|
TERF1 (TRF1)-interacting nuclear factor 2
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR5
|
toll-like receptor 5
|
|
TLR7
|
toll-like receptor 7
|
|
TLR9
|
toll-like receptor 9
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFRSF25
|
tumor necrosis factor receptor superfamily, member 25
|
|
TNFRSF9
|
tumor necrosis factor receptor superfamily, member 9
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF14
|
tumor necrosis factor (ligand) superfamily, member 14
|
|
TNFSF15
|
tumor necrosis factor (ligand) superfamily, member 15
|
|
TNFSF18
|
tumor necrosis factor (ligand) superfamily, member 18
|
|
TNFSF4
|
tumor necrosis factor (ligand) superfamily, member 4
|
|
TNFSF9
|
tumor necrosis factor (ligand) superfamily, member 9
|
|
TNR
|
tenascin R
|
|
TOP1
|
topoisomerase (DNA) I
|
|
TOX
|
thymocyte selection-associated high mobility group box
|
|
TP53
|
tumor protein p53
|
|
TP53BP2
|
tumor protein p53 binding protein 2
|
|
TP63
|
tumor protein p63
|
|
TRA
|
T cell receptor alpha locus
|
|
TRAV24
|
T cell receptor alpha variable 24
|
|
TRB
|
T cell receptor beta locus
|
|
TRDV2
|
T cell receptor delta variable 2
|
|
TRG
|
T cell receptor gamma locus
|
|
TRGV9
|
T cell receptor gamma variable 9
|
|
TRIB2
|
tribbles pseudokinase 2
|
|
TRNT1
|
tRNA nucleotidyl transferase, CCA-adding, 1
|
|
TRPA1
|
transient receptor potential cation channel, subfamily A, member 1
|
|
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSC2
|
tuberous sclerosis 2
|
|
TTR
|
transthyretin
|
|
TXNIP
|
thioredoxin interacting protein
|
|
TYMS
|
thymidylate synthetase
|
|
TYROBP
|
TYRO protein tyrosine kinase binding protein
|
|
ULBP1
|
UL16 binding protein 1
|
|
ULBP2
|
UL16 binding protein 2
|
|
ULBP3
|
UL16 binding protein 3
|
|
UNC13D
|
unc-13 homolog D (C. elegans)
|
|
URGCP
|
upregulator of cell proliferation
|
|
VAV1
|
vav 1 guanine nucleotide exchange factor
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIP
|
vasoactive intestinal peptide
|
|
VWF
|
von Willebrand factor
|
|
WARS
|
tryptophanyl-tRNA synthetase
|
|
WAS
|
Wiskott-Aldrich syndrome
|
|
WIPF1
|
WAS/WASL interacting protein family, member 1
|
|
WRAP53
|
WD repeat containing, antisense to TP53
|
|
WT1
|
Wilms tumor 1
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
ZBTB16
|
zinc finger and BTB domain containing 16
|
